Will Anti-Obesity Drugs Disrupt the MedTech Industry?
Thoughts on the Market - Un podcast de Morgan Stanley
Catégories:
Investors worry that anti-obesity drugs could dent demand for medical procedures and devices. Here’s what they could be missing.
